Patent application number | Description | Published |
20090149511 | Administration of an Inhibitor of HDAC and an mTOR Inhibitor - Methods of treating patients with an HDAC inhibitor and an mTOR inhibitor are provided. | 06-11-2009 |
20100267779 | Novel Compounds and Methods of Using Them - Described herein are novel HDAC inhibitors, formulations containing them and methods of using them. In some embodiments, the HDAC inhibitors possess specific stereochemistry. In other embodiments, the compounds described herein are used in the treatment or prevention of histone deacetylase mediated disorders. | 10-21-2010 |
20100298270 | Novel Compounds and Methods of Using Them - Described herein are novel HDAC modulators, formulations containing them and methods of using them. In some embodiments, the HDAC modulators possess specific stereo chemistry. In other embodiments, the compounds described herein are used in the treatment or prevention of histone deacetylase mediated disorders. | 11-25-2010 |
20100305167 | Administration of an Inhibitor of HDAC - Methods of treating patients with SNDX-275 are provided. | 12-02-2010 |
20130150386 | METHODS FOR THE TREATMENT OF LUNG CANCER - Described herein are methods for the treatment of lung cancer in a subject. In particular, methods are provided for the treatment of resistant lung cancer with a combination of entinostat and an EGFR inhibitor. | 06-13-2013 |
20140378420 | METHODS FOR THE TREATMENT OF BREAST CANCER - Described herein are methods for the treatment of breast cancer in a subject. In particular, methods are provided for the treatment of resistant, metastatic breast cancer with a combination of entinostat and an aromatase inhibitor. | 12-25-2014 |